In early 2024, the Parliamentray Office of Science & Technology (POST) conducted a comprehensive consultation with hundreds of experts from across the UK to identify pressing issues that parliament might need to address within the next five years.
Through this extensive consultation, over 100 significant issues were identified, spanning a wide range of topics, from prison reform and countering extremism to rebuilding trust in public institutions and preventing disease. POST are now in the process of preparing articles on many of these issues to assist parliamentary Select Committees and Govt departments in determining appropriate courses of action.
Emeritus Prof. John Oliver has been advising POSTs Horizon Scanning & Foresight Committee on a range of methodology and policy issues. Indeed, his research into horizon scanning and scenario planning has been used to underpin the methodological process involved in the consultation.
More information can be found on the link below and will provide BU researhcers with a valuable insight into the questions that will guide societal and economic impact from their research. It will also build the ‘Case for Support’ in funding applications.
https://post.parliament.uk/horizon-scan-2024/#heading-1
Good luck!
Emeritus Prof. John Oliver
Prof John Oliver appointed to Horizon & Foresight Scanning Board
A “step change” in parliamentray foresight capabilities
Leveraging the value of ‘capacity-building’ research impact!
Dr John Oliver awarded Parliamentary Fellowship










BU PhD student attending HIV conference on scholarship
ESRC SWDTP – Applications open for PhD Studentships for September 2026
New paper by CMWH PhD student
Further CMWH contributions to 2026 ICM congress
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease